3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
4
Triple Negative Breast Neoplasms
3
Hodgkin Disease
3
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Rhabdomyosarcoma
2
Neoplasm Metastasis
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Neoplasms
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
HR+HER2- Breast Cancer
1
Desmoplastic Small Round Cell Tumor
1
Adenocarcinoma
1
Interventions
Temozolomide
7
Vincristine
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Magnetic Resonance Spectroscopy
4
Irinotecan
4
Cyclophosphamide
4
cabozantinib
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
liposomal doxorubicin
2
ivosidenib
2
Topotecan
2
Radiation
2
Nuclear Medicine Department, Hospital
2
LY3023414
2
Eflornithine
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
talazoparib
1
silmitasertib
1
romiplostim
1
regorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Vinorelbine
×
90 days
×
Clear all
No trials found.